GENPACT

Genpact supporting embecta's spin-off as independent leader in diabetes technology market

The company initially supported embecta's spin-off from BD and over time, the partnership has evolved to modernise embecta’s operations. More specifically, the organisation supported the implementation of a robust ERP and launched an operating model with standardised global processes to meet the needs of a newly formed medical device company.